Showing results (61-70 of 223) with videos related to
Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|November 8, 2020
Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumourPhilippe A Cassier, Antoine Italiano, Carlos Gomez-Roca, et al.Investigational New Drugs|February 12, 2013
Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neckJean-Pascal Machiels, Marie-Christine Kaminsky, Ulrich Keller, et al.Computers in Biology and Medicine|October 28, 2017
Comparison of variable selection methods for high-dimensional survival data with competing eventsJulia Gilhodes, Christophe Zemmour, Soufiane Ajana, et al.Nature Medicine|April 8, 2025
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trialOlivier Trédan, Damien Pouessel, Nicolas Penel, et al.British Journal of Cancer|January 17, 2018
Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2Rastislav Bahleda, Andrea Varga, Yann Bergé, et al.Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Design and Mechanism of Action of a New Prototype of Combi-Molecule "Programed" to Release Bioactive Species at a pH Range Akin to That of the Tumor MicroenvironmentAnne-Laure Larroque-Lombard, Etienne Chatelut, Jean-Pierre Delord, et al.Clinical Lung Cancer|April 24, 2016
Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the LungMony Ung, Isabelle Rouquette, Thomas Filleron, et al.Head & Neck|July 14, 2012
Gene expression profiling on pre- and post-erlotinib tumors from patients with head and neck squamous cell carcinomaFabienne Thomas, Paul Delmar, Sébastien Vergez, et al.BMJ Open|January 30, 2023
Study protocol of the CREDO randomised controlled trial: evaluation of a structured return home consultation for patients suffering from metastaticcancerLaëtitia Gimenez, Pascale Grosclaude, Vladimir Druel, et al.Journal for Immunotherapy of Cancer|October 24, 2020
Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patientsJean-Pascal Machiels, Carlos Gomez-Roca, Jean-Marie Michot, et al.Pageof 23